ClinicalTrials.Veeva

Menu

Unbound Bilirubin Levels in Healthy Term and Late Preterm Infants

Rutgers The State University of New Jersey logo

Rutgers The State University of New Jersey

Status

Unknown

Conditions

Neonatal Jaundice

Treatments

Other: Assessment of unbound bilirubin levels

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Specific Aim 1: To determine total serum bilirubin (TSB) and unbound bilirubin (Bf) levels in term and late preterm infants during the first week of life.

Specific Aim 2: Measure Bf levels in breast fed and formula fed infants and examine their relationship to unbound fatty acid (FFAu) levels.

Specific Aim 3: To demonstrate that phototherapy results in different changes in TSB and Bf.

Enrollment

180 estimated patients

Sex

All

Ages

6 hours to 7 days old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Term and late-preterm infants admitted to the regular care nursery of Robert Wood Johnson University Hospital will be eligible for the study

Exclusion criteria

  • Infants suffering from genetic, chromosomal or surgical conditions will be excluded.

Trial design

180 participants in 2 patient groups

Breast fed cohort
Treatment:
Other: Assessment of unbound bilirubin levels
Formula fed cohort
Treatment:
Other: Assessment of unbound bilirubin levels

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems